Integral Health Asset Management, LLC Exelixis, Inc. Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $3.59 Million - $5.11 Million	-200,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$20.53 - $25.22 $4.11 Million - $5.04 Million	200,000 New	200,000 $4.52 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $3.1 Million - $4.04 Million	-150,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $2.17 Million - $3.27 Million	150,000 New	150,000 $2.58 Million

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.